The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 1,927,640 | 67,400 | SH | SOLE | 67,400 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,747,504 | 121,200 | SH | SOLE | 121,200 | 0 | 0 | |||
| CURIS INC | COM | 231269309 | 4,586,607 | 421,951 | SH | SOLE | 421,951 | 0 | 0 | |||
| FRACTYL HEALTH INC | COM | 35168W103 | 13,735,266 | 1,856,117 | SH | SOLE | 1,856,117 | 0 | 0 | |||
| INVIVYD INC | COM | 00534A102 | 41,062,230 | 9,248,250 | SH | SOLE | 9,248,250 | 0 | 0 | |||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 2,334,548 | 1,019,498 | SH | SOLE | 1,019,498 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 10,390,219 | 385,680 | SH | SOLE | 385,680 | 0 | 0 | |||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 6,467,040 | 299,400 | SH | SOLE | 299,400 | 0 | 0 | |||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 5,433,888 | 110,400 | SH | SOLE | 110,400 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 2,457,936 | 161,600 | SH | SOLE | 161,600 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 43,190,000 | 7,000,000 | SH | SOLE | 7,000,000 | 0 | 0 | |||